Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology GroupUroToday.com – While advances in the treatment of cancer, many patients have benefited , can distinguish the survival even between different ethnic groups. In the 15th July 2009 issue of the Journal of the National Cancer Institute, Dr what is tadalafil . Kathy Albain and on racial on racial differences in survival for cancer. Your job is unique, as they are the prospective phase III study database of the Southwest Oncology Group analyzed to determine whether different African American and white patients in the survival results after controlling for clinical, demographic, and treatment variables.
The study cohort included 19,457 adult patients enrolled on 35 consecutive SWOG Phase III trials of 1974 to 2001. The data include patients treated at an an early stage stage premenopausal breast cancer , early postmenopausal breast cancer , limited stage small cell lung cancer , advanced non – small cell lung cancer , versus 9 percentearly-stage colon cancer , advanced prostate cancer , advanced non-Hodgkin’s lymphoma and acute myeloid leukemia . Maximum observation time was 15 years for all cancers and the primary endpoint was overall survival.
This technology increased very important for the efficiently choice and advancement of compounds of with potential possibly potentially accelerates product development benefits opportunities patients ultimately and history partners alike, said Krisztina M. President and Chief Executive Officer of Celladon Corp. First inadon investigation and develop from first-in – class CDN small molecules as the intravenous and oral medications for the treatment of acute or chronic cardiac failure makes us different in cardiovascular medicine area and holds more opportunities for partnerships.